ceftazidime-monobactam and Pseudomonas-Infections

ceftazidime-monobactam has been researched along with Pseudomonas-Infections* in 2 studies

Other Studies

2 other study(ies) available for ceftazidime-monobactam and Pseudomonas-Infections

Article	Year
[Pseudomonas stutzeri osteitis: A case study]. Medecine et maladies infectieuses, 2006, Volume: 36, Issue:10 We report a case of osteitis in a 46-year-old patient, caused by Pseudomonas stutzeri following an open fracture of the left femur. The patient was treated with 1g ceftazidime every 8 hours for two weeks combined with 160 mg/day of amikacin for 10 days. A second-line ofloxacin oral treatment at 400 mg/day was then given during 4 weeks. Surgical treatment consisted in debridement of the fracture region. Sterilization of the fracture region led to an osteosynthesis by blade plate and bone graft. The result was favorable. Topics: Anti-Bacterial Agents; Ceftazidime; Drug Administration Schedule; Femoral Fractures; Humans; Male; Middle Aged; Monobactams; Pseudomonas Infections; Pseudomonas stutzeri; Treatment Outcome	2006
[Cefoperazone, cefsulodin and ceftazidime--3 cephalosporins active against Pseudomonas in comparison with their monobactam analogs]. Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectious..., 1983, Volume: 254, Issue:2 This study compares the in vitro activity of three cephalosporins - ceftazidime, cefoperazone, cefsulodin and their monobactam analogues for 144 strains of Pseudomonas aeruginosa. Media variation studies are performed and the effect of human serum and anaerobic conditions on MIC is investigated. A significant inoculum effect is considered as a sign of instability against beta-lactamases. Ceftazidine inhibits nearly all pseudomonads at concentrations between 2 and 4 micrograms/ml being significantly more active than the other antibiotics tested. The level of activity of all monobactams tested is lower than that of the homologous cephalosporins. The counterpart of ceftazidine is also the most effective monobactam but the counterpart of cefsulodin shows no activity against pseudomonads. Topics: beta-Lactamase Inhibitors; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Humans; Monobactams; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam	1983

Article

Year

[Pseudomonas stutzeri osteitis: A case study].

Medecine et maladies infectieuses, 2006, Volume: 36, Issue:10

We report a case of osteitis in a 46-year-old patient, caused by Pseudomonas stutzeri following an open fracture of the left femur. The patient was treated with 1g ceftazidime every 8 hours for two weeks combined with 160 mg/day of amikacin for 10 days. A second-line ofloxacin oral treatment at 400 mg/day was then given during 4 weeks. Surgical treatment consisted in debridement of the fracture region. Sterilization of the fracture region led to an osteosynthesis by blade plate and bone graft. The result was favorable.

Topics: Anti-Bacterial Agents; Ceftazidime; Drug Administration Schedule; Femoral Fractures; Humans; Male; Middle Aged; Monobactams; Pseudomonas Infections; Pseudomonas stutzeri; Treatment Outcome

2006

[Cefoperazone, cefsulodin and ceftazidime--3 cephalosporins active against Pseudomonas in comparison with their monobactam analogs].

Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectious..., 1983, Volume: 254, Issue:2

This study compares the in vitro activity of three cephalosporins - ceftazidime, cefoperazone, cefsulodin and their monobactam analogues for 144 strains of Pseudomonas aeruginosa. Media variation studies are performed and the effect of human serum and anaerobic conditions on MIC is investigated. A significant inoculum effect is considered as a sign of instability against beta-lactamases. Ceftazidine inhibits nearly all pseudomonads at concentrations between 2 and 4 micrograms/ml being significantly more active than the other antibiotics tested. The level of activity of all monobactams tested is lower than that of the homologous cephalosporins. The counterpart of ceftazidine is also the most effective monobactam but the counterpart of cefsulodin shows no activity against pseudomonads.

Topics: beta-Lactamase Inhibitors; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Humans; Monobactams; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam

1983